Anti-Infectives Report 2002

The anti-infectives market is poised to experience considerable growth in the next few years, with a forecast market value that is expected to double in size to more than $44 billion by 2010.

Opportunities for investment, research and development in this therapeutic area are rapidly emerging, as market-leading brands such as GlaxoSmithKline's Augmentin face patent expiration, the wrath of new legislation, intense competition from generic copycats and new therapeutic products.

This report contains

· Industry facts & figures

· Company profiles of key players in the market

· In-depth tables & graphs in easy-to-read formats

· Latest news, research & developments

· Background information to major drug classes & diseases

· Explanation of modes of drug action

· Pipeline products in development

· Analysis of market-leading drugs

· Five-year forecast of the anti-infectives market

· Company-by-company breakdown of leading players

Recent FDA approved drugs such as Eli Lilly's Xigris for sepsis has the potential to become a blockbuster product, while pipeline drugs such as AstraZeneca's Oxazolidinone antibiotic could pave the way for a whole new generation of anti-infective drugs.

Why you must buy this report

· Gain a valuable & comprehensive insight into the anti-infectives market

· Latest industry news, research & developments in this therapeutic sector · Overview of key issues that affect the success of new anti-infective products

· Understand the significance of antibiotic drug resistance in pathogens

· In-depth analysis of market trends, global sales of leading products · Identify the major players, level of competition & hot areas of research · Product pipeline for anti-infective medications of all classes · Global problem of infectious disease & demands for new anti-infective drugs · Profiles of companies with a strong product pipeline & market-leading brand products · Identify hot areas of research & development, and up · Revenue forecast for new FDA approved anti-infective drugs with blockbuster potentials · Projections for the future of the anti-infectives market

This visiongain report provides you with the most up-to-date and comprehensive guide to the anti-infectives market. With 80+ uniquely compiled tables of facts and figures, 45+ multicolored graphs, company profiles of the key players, new product information, revenue forecasts, market projections, latest news and developments, you must order this 350-page report now?

Take advantage of this high-level independent information to enhance your strategic decision making.

- PRICING -

Individual report pricing - single user copies of this report are available for only US$3485.00. Allow your whole company to have access to this information for only the price of 3 copies. Company-wide License (CD Rom and .pdf for company intranet use) for only US$9999.00.

Size: 350 pages

View Table of Contents

To order - click here!